Atlas Trials

Natriuretic Peptides as a Prognostic and Risk Stratification Tool in Assessment of Valvular Heart Disease

Clinical trial NCT05439369 · UNKNOWN

Trial details

NCT number
NCT05439369
Sponsor
Assiut University
Status
UNKNOWN
Study type
OBSERVATIONAL
Valvular Heart Disease Stenosis and Regurgitation
Start date
2022-08-01
Primary completion
2023-01-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.